Matches in Nanopublications for { ?s ?p "[Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP282068.RAA0asMfn0c-6EilQqmyrGUJlzc9v7RnmKAql0VF2FNy4130_assertion description "[Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282068.RAA0asMfn0c-6EilQqmyrGUJlzc9v7RnmKAql0VF2FNy4130_provenance.
- NP192427.RAgi5rJAt-NyOdFsaqPxb0KWQPHoV3fVDKBpC1Vfxw-b0130_assertion description "[Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP192427.RAgi5rJAt-NyOdFsaqPxb0KWQPHoV3fVDKBpC1Vfxw-b0130_provenance.
- NP790337.RASZ_Lg6iKff741bJ5AlXiIP0-dyZ5VFEoX3BZIkinRhU130_assertion description "[Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP790337.RASZ_Lg6iKff741bJ5AlXiIP0-dyZ5VFEoX3BZIkinRhU130_provenance.
- NP786702.RA0AS9oep-VLGc5qY5hqH0HNnv900vHyfQsdtNg_fA-1M130_assertion description "[Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786702.RA0AS9oep-VLGc5qY5hqH0HNnv900vHyfQsdtNg_fA-1M130_provenance.
- assertion description "[Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP754399.RAUQpTghAGQnv7Y8wCH1tDehDVgLdndaYvpRAdhLfkZyg130_assertion description "[Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754399.RAUQpTghAGQnv7Y8wCH1tDehDVgLdndaYvpRAdhLfkZyg130_provenance.
- NP754400.RAcF2gJm-6kNrdgWqF7o73KCBRG4ce3vs9U-SPc8UFnNA130_assertion description "[Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754400.RAcF2gJm-6kNrdgWqF7o73KCBRG4ce3vs9U-SPc8UFnNA130_provenance.
- NP545145.RAq_tq_S7ooom4iSvKidJX9DS0HwGH7U_6Vlv6_lELOnc130_assertion description "[Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545145.RAq_tq_S7ooom4iSvKidJX9DS0HwGH7U_6Vlv6_lELOnc130_provenance.
- NP289656.RA27qO8U6hKu5zB0paSjE2pRilRdrWl-ZB9qJSaFrWao4130_assertion description "[Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP289656.RA27qO8U6hKu5zB0paSjE2pRilRdrWl-ZB9qJSaFrWao4130_provenance.
- NP754389.RAF-XO-9-Z7p1t-vLf6SIUns2kOl37nirvqtzf6B7xMyU130_assertion description "[Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754389.RAF-XO-9-Z7p1t-vLf6SIUns2kOl37nirvqtzf6B7xMyU130_provenance.
- NP754398.RAMNjfp2Xo67rWB8csMM3sx-LW6RP0gI72s5ivdrN3zwQ130_assertion description "[Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754398.RAMNjfp2Xo67rWB8csMM3sx-LW6RP0gI72s5ivdrN3zwQ130_provenance.
- NP932306.RA0sjLdWI1opPXCZIQIdZbJ6MUnAeGWMO9GaTeUsxkq4o130_assertion description "[Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932306.RA0sjLdWI1opPXCZIQIdZbJ6MUnAeGWMO9GaTeUsxkq4o130_provenance.
- NP964967.RA7kGohvju50WnMZMlOrCH2iNhJs1OPXCHdJDjD_B6_LY130_assertion description "[Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964967.RA7kGohvju50WnMZMlOrCH2iNhJs1OPXCHdJDjD_B6_LY130_provenance.